Literature DB >> 22313532

Stem cells in human normal endometrium and endometrial cancer cells: characterization of side population cells.

Kiyoko Kato1.   

Abstract

Recently, adult stem cells have been identified in several mature tissues. The human endometrium is responsive to sex steroid hormone. It undergoes extraordinary growth in a cyclic manner and is shed and regenerated throughout a woman's lifetime. It has been proposed that the human endometrium may contain a population of stem cells, which are responsible for its remarkable regenerative ability. It is also suggested that stem-like cells exist in cancer tissues. Stem-like cell subpopulations, referred to as "side population" (SP) cells, have been identified in several tissues and tumors based on their ability to efflux the fluorescent dye Hoechst 33342. Recently, we isolated and characterized the SP cells in normal human endometrium and in an endometrial cancer (EC) cell line. Endometrial SP cells can function as progenitor cells. EC SP cells show the following: (1) reductions in the expression levels of differentiation markers; (2) long-term repopulating properties; (3) self-renewal capacity; (4) enhancement of migration and podia formation; (5) enhancement of tumorigenicity; and (6) bipotent developmental potential (tumor cells and stroma-like cells), suggesting that these SP cells have cancer stem-like cell features. We review the articles that show the presence of stem cells in normal endometrium and EC cells and demonstrate the results of our studies.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 22313532     DOI: 10.1016/j.kjms.2011.06.028

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  9 in total

Review 1.  Stem cell and endometriosis: new knowledge may be producing novel therapies.

Authors:  Jing Yang; Fengying Huang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 2.  Molecular cues on obesity signals, tumor markers and endometrial cancer.

Authors:  Danielle Daley-Brown; Gabriela M Oprea-Ilies; Regina Lee; Roland Pattillo; Ruben R Gonzalez-Perez
Journal:  Horm Mol Biol Clin Investig       Date:  2015-01

3.  Very small embryonic-like stem cells are the elusive mouse endometrial stem cells--a pilot study.

Authors:  Pranesh Gunjal; Deepa Bhartiya; Siddhanath Metkari; Dhananjay Manjramkar; Hiren Patel
Journal:  J Ovarian Res       Date:  2015-03-11       Impact factor: 4.234

4.  Direct reprogramming of epithelial cell rests of malassez into mesenchymal-like cells by epigenetic agents.

Authors:  Koki Yoshida; Osamu Uehara; Yoshihito Kurashige; Durga Paudel; Aya Onishi; Puja Neopane; Daichi Hiraki; Tetsuro Morikawa; Fumiya Harada; Rie Takai; Jun Sato; Masato Saitoh; Yoshihiro Abiko
Journal:  Sci Rep       Date:  2021-01-20       Impact factor: 4.379

Review 5.  Emerging therapeutic biomarkers in endometrial cancer.

Authors:  Peixin Dong; Masanori Kaneuchi; Yosuke Konno; Hidemichi Watari; Satoko Sudo; Noriaki Sakuragi
Journal:  Biomed Res Int       Date:  2013-06-11       Impact factor: 3.411

6.  Identification of cancer stem-like side population cells in purified primary cultured human laryngeal squamous cell carcinoma epithelia.

Authors:  Chun-Ping Wu; Liang Zhou; Ming Xie; Huai-Dong Du; Jie Tian; Shan Sun; Jin-Yan Li
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

Review 7.  Theories on the pathogenesis of endometriosis.

Authors:  Samer Sourial; Nicola Tempest; Dharani K Hapangama
Journal:  Int J Reprod Med       Date:  2014-02-12

8.  Role of MicroRNAs in carcinogenesis that potential for biomarker of endometrial cancer.

Authors:  Muhammad Sasmito Djati; Muhaimin Rifa'i
Journal:  Ann Med Surg (Lond)       Date:  2016-02-26

9.  Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathway.

Authors:  Amber A Bokhari; Tabari M Baker; Batsukh Dorjbal; Sana Waheed; Christopher M Zahn; Chad A Hamilton; G Larry Maxwell; Viqar Syed
Journal:  Oncotarget       Date:  2016-10-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.